Clinical trials for Pancreas cancer
159 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 1
Lung cancer
Colon cancer
Rectal cancer
Pancreas cancer
Stomach and esophageal cancer
#NCT06131840
NSCLC (Non-Small Cell Lung Cancer)
Stomach
Oesogastric junction
Adenocarcinoma
Locally Advanced
Metastatic
1
2
3 or more
1 recruiting site
Seagen
Phase 1
Pancreas cancer
#NCT06131840
Partie E Adénocarcinome canalaire pancréatique
Adenocarcinoma
Metastatic
None
1
Systemic Treatment-Naive
Chemotherapy
1 recruiting site
Seagen
Phase 1
Pancreas cancer
#NCT06360354
Adenocarcinoma
Locally Advanced
Metastatic
MTAP
1
2
3 or more
Systemic Treatment-Naive
4 recruiting sites
Amgen
Phase 1
Pancreas cancer
#NCT06360354
Adenocarcinoma
Locally Advanced
Metastatic
Other KRAS
HRAS
KRAS G12C
KRAS non G12C
KRAS G12D
MTAP
NRAS
1
2
3 or more
4 recruiting sites
Amgen
Phase 1
Breast cancer
Lung cancer
Pancreas cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT05143970
Partie I Escalade de dose
Stomach
Esophagus
Epithelial ovarian cancer
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
1 recruiting site
Institut Paoli Calmettes
Phase 1
Pancreas cancer
#NCT07261631
#2025-521702-18-00
Cohorte Adénocarcinome canalaire pancréatique
Adenocarcinoma
Locally Advanced
Metastatic
1
2
3 or more
Chemotherapy
Systemic Treatment-Naive
1 recruiting site
Novartis
Phase 1
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
Head and neck cancer
#NCT06781983
Locally Advanced
Metastatic
Other mutation
1
2
3 or more
Systemic Treatment-Naive
2 recruiting sites
Innate Pharma
Phase 1
Colon cancer
Rectal cancer
Pancreas cancer
Head and neck cancer
#NCT06305247
Oral cavity
Nasopharynx
Oropharynx
Hypopharynx
Larynx
Nasal cavities and sinuses
Adenocarcinoma
Squamous cell carcinoma
Metastatic
Other mutation
1
2
3 or more
Systemic Treatment-Naive
4 recruiting sites
Epizyme, Inc. (Ipsen)
Phase 1
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
Head and neck cancer
#NCT04777994
Dose d'expansion cohorte combinaison avec inhibiteur PD-1 tumeurs MSI-H
Locally Advanced
Metastatic
MSI/dMMR
1
2
3 or more
Immunotherapy
Systemic Treatment-Naive
4 recruiting sites
Calico Life Sciences LLC
Phase 1
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
Head and neck cancer
#NCT04777994
Escalade de dose (Tumeurs solides)
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
4 recruiting sites
Calico Life Sciences LLC